Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELAKS: Ketamine Mechanisms in Healthy Volunteers
NCT04850911Unknown
- Sponsor
- University of Oxford
- Start
- Aug 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Ketamine with Placebo (2 arms). Primary endpoints: Activation of the habenula during Pavlovian conditioning, Habenula response to reward omission and unexpected loss and 1 more. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04850911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850911.